Athanase Innovation AB (ATHAN)

Stockholm

Currency in SEK

14.4000

0.0000(0.00%)

Closed·30/04

Fair Value

Unlock Value

Day's Range

14.4000

52 wk Range

10.0000

23.0000

ATHAN Income Statement

Assess the Athanase Innovation AB income statement, providing a detailed view of the company’s financial performance across activities. This statement outlines key financial figures such as revenue, expenses, operating income, and net income. Assess the ATHAN net worth.

Period Ending:

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

2025

31/12

Total Revenues

aa.aa

168.75

47.55

Total Revenues Growth

aa.aa

+315.63%

-71.82%

Cost Of Revenues

aa.aa

88.24

17.89

Gross Profit

aa.aa

80.51

29.65

Gross Profit Growth

aa.aa

+352.72%

-63.17%

Gross Profit Margin %

aa.aa

47.71%

62.37%

Other Operating Expenses, Total

aa.aa

97.92

93.73

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+2.52%	-4.28%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	91.92	86.26
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-7.65	-6.65

Operating Income

aa.aa

-17.41

-64.08

Operating Income Growth

aa.aa

+77.6%

-268.02%

EBIT Margin %

aa.aa

-10.32%

-134.78%

Net Interest Expenses

aa.aa

12.42

5.69

Net Interest Expenses Growth

aa.aa

-23.64%

-54.22%

Interest Expense, Total

aa.aa

-0.61

-0.86

Interest And Investment Income

aa.aa

13.03

6.54

Other Non Operating Expenses, Total

aa.aa

-6.15

0.11

EBT, Excl. Unusual Items

aa.aa

-11.14

-58.28

Gain (Loss) On Sale Of Assets

aa.aa

Other Unusual Items, Total

aa.aa

EBT, Incl. Unusual Items

aa.aa

-19.64

-58.28

EBT, Incl. Unusual Items Growth

aa.aa

+70.78%

-196.7%

EBT, Incl. Unusual Items Margin

aa.aa

-11.64%

-122.59%

Income Tax Expense

aa.aa

-0

0.33

Net Income to Company

aa.aa

-19.64

-58.62

Minority Interest

aa.aa

0.99

Net Income

aa.aa

-19.64

-57.62

Net Income Growth

aa.aa

+65.09%

-193.39%

Net Income Margin %

aa.aa

-11.64%

-121.19%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

-19.64

-57.62

Basic EPS - Continuing Operations

aa.aa

-0.83

-2.99

Basic EPS - Continuing Operations Growth

aa.aa

+56.25%

-261.18%

Diluted EPS - Continuing Operations

aa.aa

-0.83

-2.99

Diluted EPS - Continuing Operations Growth

aa.aa

+56.25%

-261.18%

Basic Weighted Average Shares Outstanding

aa.aa

23.76

19.3

Diluted Weighted Average Shares Outstanding

aa.aa

23.76

19.3

Dividend Per Share

aa.aa

Dividend Per Share Growth

aa.aa

EBITDA

aa.aa

-3.97

-50.66

EBITDA Growth

aa.aa

+93.74%

-1,175.67%

EBITDA Margin %

aa.aa

-2.35%

-106.55%

EBIT

aa.aa

-17.41

-64.08

* In Millions of SEK (except for per share items)

FAQ

What was Athanase Innovation AB’s revenue at year end?

At the end of the last reported fiscal year, Athanase Innovation AB (ATHAN) recorded total revenue of 47.5450 million SEK.

How much revenue did Athanase Innovation AB report in the most recent quarter?

In its most recent quarterly earnings report, Athanase Innovation AB posted revenue of 24.6870 million SEK.

What was Athanase Innovation AB’s net income for the year?

For the full year, Athanase Innovation AB reported net income of -57.6210 million SEK.

How much net income did Athanase Innovation AB post in the last quarter?

In the most recent quarter, Athanase Innovation AB (ATHAN) posted net income of -9.4360 million SEK.

What was Athanase Innovation AB’s gross profit for the year?

Gross profit for the year was reported at 29.6540 million SEK.

How much gross profit did Athanase Innovation AB generate last quarter?

Athanase Innovation AB recorded gross profit of 14.7630 million SEK in its latest quarterly report.

What was Athanase Innovation AB’s annual operating income?

For the full year, Athanase Innovation AB (ATHAN) reported operating income of -64.0790 million SEK.

What was Athanase Innovation AB’s operating income last quarter?

Quarterly operating income was -9.4320 million SEK.

What was Athanase Innovation AB’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at -6.5720 million SEK.

What was the quarter-over-quarter change in EBITDA for Athanase Innovation AB?

EBITDA changed by 55.3381% million SEK compared to the last quarter.

What is Athanase Innovation AB’s most recent gross profit margin?

The latest reported gross profit margin for Athanase Innovation AB (ATHAN) is 59.8007% million SEK.

What is Athanase Innovation AB’s most recent net income margin?

Net income margin based on recent financials is -38.2225% million SEK.

What is Athanase Innovation AB’s most recent EBIT margin?

Athanase Innovation AB reported an EBIT margin of -38.2063% million SEK based on current figures.

How did Athanase Innovation AB’s revenue change compared to the previous quarter?

Revenue changed by 93.6691% million SEK compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for Athanase Innovation AB?

In the latest quarter, gross profit changed by 83.4597% million SEK from the previous quarter.

S&P/TSX

33,891.18

-73.15

-0.22%

S&P/TSX 60

1,977.80

-4.92

-0.25%

US 30

49,454.30

-197.6

-0.40%

US 500

7,219.80

+10.8

+0.15%

S&P 500 VIX

16.99

+0.10

+0.59%

DAX

24,292.38

+337.82

+1.41%

Dollar Index

98.01

+0.090

+0.09%

Market Movers

Name	Last	Chg. %	Vol.
Canadian Natural	63.88	-1.48%	9.01M
TC Energy	90.63	-0.49%	4.98M
Toronto Dominion Bank	145.84	-0.33%	4.70M
Bank of Nova Scotia	106.05	+0.35%	4.24M
Bank of Montreal	207.41	+0.28%	2.07M
RBC	244.20	-0.05%	1.51M
Fairfax Financial	2,170.28	-7.67%	168.83K

Name	Last	Chg. %	Vol.
PeakBirch Logic	0.030	+500.00%	1.32K
Vertiqal Studios	0.01	+200.00%	146.72K
Vertiqal Studios	0.01	+200.00%	146.72K
Irwin Naturals	0.30	+150.00%	3.24K
Taurus Gold	0.07	+150.00%	46.05K
Green Scientific Labs Holdings	0.06	+120.00%	15.00K
ePlay Digital	0.010	+100.00%	7.00K

Name	Last	Chg. %	Vol.
Nirvana Life Sciences	0.01	-75.00%	8.00K
Resource Centrix Holdings	1.50	-60.00%	600.00
Noveris Health Sciences	0.80	-57.67%	46.86K
Noveris Health Sciences	0.800	-57.67%	46.86K
Patriot Gold	0.07	-51.85%	1.00K
Armada Mercantile Ltd	0.135	-51.79%	7.00K
Molecule Holdings	0.005	-50.00%	20.11K

Trending Stocks

Name	Last	Chg. %	Vol.
TELUS	17.07	+0.35%	4.16M
Air Canada	18.26	-2.09%	5.48M
Celestica Inc.	569.51	+2.12%	347.49K
Toronto Dominion Bank	145.84	-0.33%	4.70M
Canadian Natural	63.88	-1.48%	9.01M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaa A Aaa	90.41	+62.23%	146.67
Aaaaaa	5.35	+61.22%	8.63
Aaaaaaaaa	17.39	+55.14%	26.98
Aaaaaa Aaaa	5.93	+52.62%	9.05
Aaaaaaaaaaaaaaaaaaa	11.26	+42.54%	16.05
Aa Aaaaaaaaaa	10.80	+41.53%	15.29
A Aaaaaaaa	23.88	+36.64%	32.63

Name	Last	Upside	Fair Value
Aaa A Aaa	90.41	+62.23%	146.67
Aaaaaa	5.35	+61.22%	8.63
Aaaaaaaaa	17.39	+55.14%	26.98
Aaaaaa Aaaa	5.93	+52.62%	9.05
Aaaaaaaaaaaaaaaaaaa	11.26	+42.54%	16.05
Aa Aaaaaaaaaa	10.80	+41.53%	15.29
A Aaaaaaaa	23.88	+36.64%	32.63

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Athanase Innovation AB (ATHAN)

ATHAN Income Statement

FAQ

What was Athanase Innovation AB’s revenue at year end?

How much revenue did Athanase Innovation AB report in the most recent quarter?

What was Athanase Innovation AB’s net income for the year?

How much net income did Athanase Innovation AB post in the last quarter?

What was Athanase Innovation AB’s gross profit for the year?

How much gross profit did Athanase Innovation AB generate last quarter?

What was Athanase Innovation AB’s annual operating income?

What was Athanase Innovation AB’s operating income last quarter?

What was Athanase Innovation AB’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for Athanase Innovation AB?

What is Athanase Innovation AB’s most recent gross profit margin?

What is Athanase Innovation AB’s most recent net income margin?

What is Athanase Innovation AB’s most recent EBIT margin?

How did Athanase Innovation AB’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for Athanase Innovation AB?

Trending Stocks